Evotec SE (EVO)
$1.35-1.46%Close
SELLCRISIS · day 5
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $480M
- Beta
- 1.26
- P/E (TTM)
- -2.21
- Short % float
- 0.01%
- Days to cover
- 1.0
- SI change
- -78.5%
- 1W
- -17.18%
- 1M
- -19.64%
- vs SPY 1W
- -17.04%
- vs SPY 1M
- -22.15%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on EVO?
- LOPJLB’s latest quantitative signal on Evotec SE (EVO) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is EVO in?
- Evotec SE (EVO) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Evotec SE (EVO) do?
- Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervo…